P38 MAPK and Radiotherapy: Foes or Friends?

Area of Science:

• Cellular Biology
• Radiation Oncology
• Molecular Signaling

Background:

• Cellular response to ionizing radiation (IR) is crucial in radiotherapy.
• The p38 MAPK pathway is activated by IR and affects key cellular processes.
• The exact role of p38 MAPK in radioresistance and radiotherapy improvement is not fully understood.

Purpose of the Study:

• To review the current knowledge on p38 MAPK signaling in response to IR.
• To explore the involvement of p38 MAPK in radiotherapy-related aspects.
• To assess the potential of p38 MAPK as a target for improving radiotherapy.

Main Methods:

• Literature review of studies on p38 MAPK and ionizing radiation.
• Analysis of p38 MAPK's role in cell cycle, apoptosis, and senescence post-IR.
• Examination of p38 MAPK's involvement in REDOX control, fibrosis, and radiosensitization.

Main Results:

• p38 MAPK activation by IR is consistently observed in vitro and in vivo.
• p38 MAPK influences critical cellular responses to genotoxic stress.
• Its precise contribution to radioresistance/sensitivity requires further elucidation.

Conclusions:

• p38 MAPK is a significant player in the cellular response to IR.
• Understanding p38 MAPK's function is vital for optimizing radiotherapy strategies.
• Targeting p38 MAPK may offer novel approaches to enhance radiosensitization.